These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging. Engle SK; Solter PF; Credille KM; Bull CM; Adams S; Berna MJ; Schultze AE; Rothstein EC; Cockman MD; Pritt ML; Liu H; Lu Y; Chiang AY; Watson DE Toxicol Sci; 2010 Apr; 114(2):183-92. PubMed ID: 20044590 [TBL] [Abstract][Full Text] [Related]
3. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure. Sweet ME; Cocciolo A; Slavov D; Jones KL; Sweet JR; Graw SL; Reece TB; Ambardekar AV; Bristow MR; Mestroni L; Taylor MRG BMC Genomics; 2018 Nov; 19(1):812. PubMed ID: 30419824 [TBL] [Abstract][Full Text] [Related]
4. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes. Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940 [TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension. Xue H; Wang S; Wang H; Sun K; Song X; Zhang W; Fu C; Han Y; Hui R Clin Sci (Lond); 2008 Jan; 114(2):131-7. PubMed ID: 17672826 [TBL] [Abstract][Full Text] [Related]
6. Serum uric acid level and left ventricular hypertrophy in elderly male patients with nonvalvular atrial fibrillation. Liang WY; Liu WW; Liu ML; Xiang W; Feng XR; Huang B; Chen XH; Sun YS Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):575-580. PubMed ID: 27162100 [TBL] [Abstract][Full Text] [Related]
7. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters. Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342 [TBL] [Abstract][Full Text] [Related]
8. Genetic Dissection of a Super Enhancer Controlling the Man JCK; van Duijvenboden K; Krijger PHL; Hooijkaas IB; van der Made I; de Gier-de Vries C; Wakker V; Creemers EE; de Laat W; Boukens BJ; Christoffels VM Circ Res; 2021 Jan; 128(1):115-129. PubMed ID: 33107387 [TBL] [Abstract][Full Text] [Related]
10. [Sex differences in the correlation between obesity and hypertension with left ventricular mass and hypertrophy]. Kuch B; Muscholl M; Luchner A; Döring A; Riegger GA; Schunkert H; Hense HW Z Kardiol; 1996 May; 85(5):334-42. PubMed ID: 8711946 [TBL] [Abstract][Full Text] [Related]
11. Plasma B-type natriuretic peptide level is associated with left ventricular hypertrophy among obstructive sleep apnoea patients. Usui Y; Tomiyama H; Hashimoto H; Takata Y; Inoue Y; Asano K; Kurohane S; Shiina K; Hirayama Y; Yamashina A J Hypertens; 2008 Jan; 26(1):117-23. PubMed ID: 18090548 [TBL] [Abstract][Full Text] [Related]
12. Structure and function of the Nppa-Nppb cluster locus during heart development and disease. Man J; Barnett P; Christoffels VM Cell Mol Life Sci; 2018 Apr; 75(8):1435-1444. PubMed ID: 29302701 [TBL] [Abstract][Full Text] [Related]
13. A transgenic mouse model for the simultaneous monitoring of ANF and BNP gene activity during heart development and disease. Sergeeva IA; Hooijkaas IB; Van Der Made I; Jong WM; Creemers EE; Christoffels VM Cardiovasc Res; 2014 Jan; 101(1):78-86. PubMed ID: 24104878 [TBL] [Abstract][Full Text] [Related]
14. A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study. Khouri MG; Peshock RM; Ayers CR; de Lemos JA; Drazner MH Circ Cardiovasc Imaging; 2010 Mar; 3(2):164-71. PubMed ID: 20061518 [TBL] [Abstract][Full Text] [Related]
15. Fetal-adult cardiac transcriptome analysis in rats with contrasting left ventricular mass reveals new candidates for cardiac hypertrophy. Grabowski K; Riemenschneider M; Schulte L; Witten A; Schulz A; Stoll M; Kreutz R PLoS One; 2015; 10(2):e0116807. PubMed ID: 25646840 [TBL] [Abstract][Full Text] [Related]
16. The repressor element 1-silencing transcription factor regulates heart-specific gene expression using multiple chromatin-modifying complexes. Bingham AJ; Ooi L; Kozera L; White E; Wood IC Mol Cell Biol; 2007 Jun; 27(11):4082-92. PubMed ID: 17371849 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA profiling identifies miR-7-5p and miR-26b-5p as differentially expressed in hypertensive patients with left ventricular hypertrophy. Kaneto CM; Nascimento JS; Moreira MCR; Ludovico ND; Santana AP; Silva RAA; Silva-Jardim I; Santos JL; Sousa SMB; Lima PSP Braz J Med Biol Res; 2017 Oct; 50(12):e6211. PubMed ID: 29069223 [TBL] [Abstract][Full Text] [Related]
18. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. Brugada R; Kelsey W; Lechin M; Zhao G; Yu QT; Zoghbi W; Quinones M; Elstein E; Omran A; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R; Marian AJ J Investig Med; 1997 Dec; 45(9):542-51. PubMed ID: 9444881 [TBL] [Abstract][Full Text] [Related]
19. Kinetic mRNA Profiling in a Rat Model of Left-Ventricular Hypertrophy Reveals Early Expression of Chemokines and Their Receptors. Nemska S; Monassier L; Gassmann M; Frossard N; Tavakoli R PLoS One; 2016; 11(8):e0161273. PubMed ID: 27525724 [TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptides as markers of preclinical cardiac disease in obesity. Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]